Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Nutr J. 2022 May 17;21(1):32. doi: 10.1186/s12937-022-00787-9.
The relationship between maternal vitamin D status in pregnancy and the development of atopic diseases in the offspring has been frequently studied, but with contradictory results. Previous studies have found an inverse relation between maternal vitamin D in pregnancy and the risk of atopic diseases in the child. In contrast, others have found a higher maternal 25OHD to be related to a higher risk of atopic diseases. Thus, the aim was to investigate the associations between maternal vitamin D status and intake in pregnancy with asthma, eczema and food allergies in the children up to 5 years. In addition, effect modification by reported atopic heredity was studied.
Participants in the GraviD study had 25-hydroxyvitamin D (25OHD) analyzed in serum in early (T1) and late (T3) pregnancy. Maternal dietary vitamin D intake was estimated from a short food frequency questionnaire and supplement use by questionnaires. At 5 years of age the child´s history of asthma, eczema and food allergy, including atopic heredity, was reported by questionnaire. Multivariable logistic regression was used.
The cumulative incidence of asthma was 13%, eczema 22%, and food allergy 18%. Only among children without reported atopic heredity, maternal 25OHD of 50-75 nmol/L in T1 was associated with lower odds of asthma (OR 0.271, 95% CI 0.127-0.580), compared to maternal 25OHD > 75 nmol/L. Additionally in these children, maternal 25OHD in T3 (continuous) was associated with asthma (OR 1.014, 95% CI 1.002-1.009), and dietary vitamin D intake with eczema (OR 1.141, 95% CI 1.011-1.288).
Among children without reported atopic heredity, higher maternal vitamin D status and intake during pregnancy was associated with increased risk of reported atopic disease.
母体妊娠期间维生素 D 状况与后代特应性疾病的发展之间的关系经常被研究,但结果却相互矛盾。先前的研究发现,母体妊娠期间维生素 D 与儿童特应性疾病的风险呈负相关。相比之下,其他人发现较高的母体 25-羟维生素 D 与特应性疾病的风险增加有关。因此,本研究旨在调查母体妊娠期间维生素 D 状态和摄入量与儿童 5 岁以下哮喘、湿疹和食物过敏的相关性。此外,还研究了报告的特应性遗传对这些关联的影响。
Gravid 研究的参与者在妊娠早期(T1)和晚期(T3)检测血清 25-羟维生素 D(25OHD)。通过短期食物频率问卷和问卷调查来估计母体膳食维生素 D 摄入量和补充剂使用情况。在 5 岁时,通过问卷调查报告儿童的哮喘、湿疹和食物过敏史,包括特应性遗传史。采用多变量逻辑回归。
哮喘的累积发病率为 13%,湿疹为 22%,食物过敏为 18%。只有在没有报告特应性遗传的儿童中,T1 时母体 25OHD 为 50-75 nmol/L 与哮喘的几率较低相关(OR 0.271,95%CI 0.127-0.580),而母体 25OHD > 75 nmol/L。此外,在这些儿童中,T3 时母体 25OHD(连续)与哮喘相关(OR 1.014,95%CI 1.002-1.009),而膳食维生素 D 摄入量与湿疹相关(OR 1.141,95%CI 1.011-1.288)。
在没有报告特应性遗传的儿童中,母体妊娠期间维生素 D 状态和摄入量较高与报告的特应性疾病风险增加相关。